Home HealthTopics Health Centers Reference Library Research
Join us on Facebook Join us on Facebook Share on Facebook

Pulmonary Fibrosis

Odds of Pirfenidone Approval in US



Based on the Japanese and US data, should we expect FDA to approve the drug for use in the USA fir people with IPF?


The FDA is currently reviewing the new drug application materials for pirfenidone and it is expected that they will render a decision on whether or not to approve it sometime in May 2009

For more information:

Go to the Pulmonary Fibrosis health topic, where you can:

Response by:

James N Allen, Jr, MD James N Allen, Jr, MD
Clinical Professor of Pulmonary, Allergy, Critical Care & Sleep Medicine
College of Medicine
The Ohio State University